Results 6,561-6,580 of 12,402 for speaker:Louise O'Reilly

Written Answers — Department of Health: Cancer Awareness (10 Dec 2019)

Louise O'Reilly: 461. To ask the Minister for Health further to Parliamentary Question Nos. 320, 321, 322, 324 and 325 of 26 November 2019, if a company (details supplied) or its insurers have met with his Department, the HSE, the Health Products Regulatory Authority or other Departments, offices or statutory bodies in relation to the breast implants which are now known to cause breast implant associated...

Written Answers — Department of Health: Cancer Awareness (10 Dec 2019)

Louise O'Reilly: 462. To ask the Minister for Health further to Parliamentary Question Nos. 320, 321, 322, 324 and 325 of 26 November 2019, if he, the HSE or the Health Products Regulatory Authority secured an undertaking from a company (details supplied) that it will fund the removal of implants provided to women in hospitals here which are now known to cause breast implant associated anaplastic large cell...

Written Answers — Department of Health: Cancer Awareness (10 Dec 2019)

Louise O'Reilly: 463. To ask the Minister for Health further to Parliamentary Question Nos. 320, 321, 322, 324 and 325 of 26 November 2019, the reason a freephone number was not provided on the correspondence sent to women that received breast implants known to cause breast implant associated anaplastic large cell lymphoma; and the specific training provided to the personnel manning the call lines for the...

Written Answers — Department of Health: Cancer Awareness (10 Dec 2019)

Louise O'Reilly: 464. To ask the Minister for Health further to Parliamentary Question Nos. 320, 321, 322, 324 and 325 of 26 November 2019, the reason the Health Products Regulatory Authority, the HSE or his Department did not as a precautionary measure cease ordering and distributing to participating cancer centres the textured implants of the company (details supplied) in view of the fact there were already...

Written Answers — Department of Health: Cancer Awareness (10 Dec 2019)

Louise O'Reilly: 465. To ask the Minister for Health further to Parliamentary Question Nos. 320, 321, 322, 324 and 325 of 26 November 2019, if women seeking to have the surgical removal of an implant that was provided by the State will have such a procedure provided for in a public or voluntary hospital and that there will not be a cost or charge to the woman in such an event [51886/19]

Written Answers — Department of Health: HSE Staff Recruitment (4 Dec 2019)

Louise O'Reilly: 179. To ask the Minister for Health if his attention has been drawn to the distress caused to families in the Inishowen area of County Donegal by the delays in signing off on an autism therapist post for the area to replace the previous person who stepped down from the role in 2018; and if the post will be signed off as soon as possible. [50669/19]

Confidence in the Minister for Housing, Planning and Local Government: Motion [Private Members] (3 Dec 2019)

Louise O'Reilly: Hear, hear.

An tOrd Gnó - Order of Business (3 Dec 2019)

Louise O'Reilly: On the same issue, we not only need but deserve to have a debate with questions and answers.

Written Answers — Department of Health: Community Care (3 Dec 2019)

Louise O'Reilly: 362. To ask the Minister for Health the breakdown of the home support budget for north County Dublin to date in 2019. [49913/19]

Written Answers — Department of Health: Medicinal Products Availability (27 Nov 2019)

Louise O'Reilly: 143. To ask the Minister for Health the progress made to ensure the swift provision of new medicines to persons with multiple sclerosis. [49257/19]

Written Answers — Department of Health: First Aid Training (27 Nov 2019)

Louise O'Reilly: 144. To ask the Minister for Health if life saving or first aid courses are required to include instructions on the steps to be taken if a person is choking while alone; and if he will make a statement on the matter. [49258/19]

Written Answers — Department of Health: Vaccine Damage Compensation Scheme (27 Nov 2019)

Louise O'Reilly: 161. To ask the Minister for Health the cost of fighting a case (details supplied) over the past number of years; his plans to make each person who suffered narcolepsy having been administered the pandemrix influenza vaccine go to court against the State; his further plans and timeframe to address the outstanding cases in a manner in which such persons will not have to go through the courts,...

Joint Oireachtas Committee on Health: Business of Joint Committee (27 Nov 2019)

Louise O'Reilly: I agree wholeheartedly with that. We may need to broaden it. It will be tough because there may not be a representative group. It could be possible for the committee to get the information we need by some other means. Perhaps the committee could get a submission. I am not sure how we could do it and it might prove to be tough to do. Without going into the detail, clearly there is an...

Joint Oireachtas Committee on Health: Business of Joint Committee (27 Nov 2019)

Louise O'Reilly: We also need to keep open the idea of having a meeting outside of our normal schedule, perhaps during the evening when this space would be free.

Joint Oireachtas Committee on Health: Working Group on Access to Contraception: Discussion (27 Nov 2019)

Louise O'Reilly: I welcome the witnesses and apologise in advance that I have a small cold, but I am making a massive deal out of it. It is big to me.

Joint Oireachtas Committee on Health: Working Group on Access to Contraception: Discussion (27 Nov 2019)

Louise O'Reilly: It is pure man flu I have. The working group put forward a number of possible directions: universal access, LARC, and a targeted scheme. I refer specifically to the front-line medical professionals in this regard. Do they have a view on whether it should be some or all, and what is the best way forward out of those choices? In an ideal world, what would they opt for?

Joint Oireachtas Committee on Health: Working Group on Access to Contraception: Discussion (27 Nov 2019)

Louise O'Reilly: Would the best time to incorporate that education, which could be as subtle as a chat, be immediately post-natal or immediately post-abortion so the opportunity is there to talk to that targeted group in the first instance? In that case, it would be a matter of having a chat with the person as to what suits her best and giving her the prescription. Money would not be a barrier in that case.

Joint Oireachtas Committee on Health: Working Group on Access to Contraception: Discussion (27 Nov 2019)

Louise O'Reilly: Then the window of opportunity is lost. If the person does not have the money in her back pocket when having the conversation, the window of opportunity is lost. We are all agreed on the best time to have the chat. When the opportunity is lost, the woman is lost to the system because she may not be returning for any reason. In Dr. Henchion's experience, is money an issue when having the...

Joint Oireachtas Committee on Health: Working Group on Access to Contraception: Discussion (27 Nov 2019)

Louise O'Reilly: In his submission, Mr. Conlon mentioned a figure of €80 million to €100 million. Is that based on every woman of reproductive age having access deciding to avail? Is it based on the current number if there were no charge in the morning? Alternatively, is it based on a take-up rate of 100%?

Joint Oireachtas Committee on Health: Working Group on Access to Contraception: Discussion (27 Nov 2019)

Louise O'Reilly: What is the current rate?